Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-22-002485

Director acquired 12,855 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ling Geoffrey M.D. Director 2022-01-07 Grant or award +12,855 31,790 D: show line 1 in the form
Loading xslF345X03/doc4.xml…